Full-Time

Reuters seeks a pharma industry reporter

Reuters is looking for an ambitious U.S. Pharmaceutical Industry Reporter with a track record of scoops and agenda-setting stories.

The successful candidate will break news on an industry that has suffered a major political loss in the United States and is bracing for new federal efforts to bring down the cost of prescription medicines.

This reporter would shed light on the commercial strategies of leading industry players, with a broad view on how new medicines in development will impact companies, investors, patients and providers.

At the same time, the candidate will report on how big pharma companies are turning to deals and new business opportunities after having benefited tremendously from developing vaccines and treatments critical to alleviating the COVID-19 pandemic.

The reporter would demonstrate a track record of deep source development and show how they would cultivate a roster of sources among pharmaceutical and biotech executives, government health officials and industry investors. The preferred location for the role is New York.

About the Role

As our U.S. Pharmaceutical Industry Reporter, you will:

  • Develop a diverse range of sources that lead to scoops
  • Break exclusive news that rivals must follow
  • Lead and/or reinforce coverage of major news
  • Report aggressively to hold pharmaceutical companies, government agencies and health officials accountable
  • Write deeply-reported, standback stories on changing strategies within the industry
  • Demonstrate beat expertise and dominance
  • Work with a global team of experienced reporters and editors writing about health and pharma from across the United States, Europe and Asia

About You

To be our U.S. Pharmaceutical Industry Reporter, you will likely have:

  • Strong knowledge of the pharmaceutical industry and regulations that govern it
  • Deep sourcing to be able to publish exclusive news that sets the agenda
  • Proven skill covering fast-breaking news
  • Proven record of bringing story ideas to fruition
  • Ability to understand and dissect financial disclosures
  • Demonstrated ability to multitask in a fast-moving, high-pressure environment
  • Excellent news judgment
  • Ability to work collaboratively with others across teams and geographies
  • At least 5 years’ experience reporting at a major news organization

Please note, the deadline for applications is Friday 14th October 2022.

To apply, go here.

Chris Roush

Chris Roush was the dean of the School of Communications at Quinnipiac University in Hamden, Connecticut. He was previously Walter E. Hussman Sr. Distinguished Professor in business journalism at UNC-Chapel Hill. He is a former business journalist for Bloomberg News, Businessweek, The Atlanta Journal-Constitution, The Tampa Tribune and the Sarasota Herald-Tribune. He is the author of the leading business reporting textbook "Show me the Money: Writing Business and Economics Stories for Mass Communication" and "Thinking Things Over," a biography of former Wall Street Journal editor Vermont Royster.

Recent Posts

PCWorld executive editor Ung dies at 58

PCWorld executive editor Gordon Mah Ung, a tireless journalist we once described as a founding father…

1 day ago

CNBC taps Sullivan as “Power Lunch” co-anchor

CNBC senior vice president Dan Colarusso sent out the following on Monday: Before this year comes to…

3 days ago

Business Insider hires Brooks as standards editor

Business Insider editor in chief Jamie Heller sent out the following on Monday: I'm excited to share…

3 days ago

Is this the end of CoinDesk as we know it?

Former CoinDesk editorial staffer Michael McSweeney writes about the recent happenings at the cryptocurrency news site, where…

3 days ago

LinkedIn finance editor Singh departs

Manas Pratap Singh, finance editor for LinkedIn News Europe, has left for a new opportunity…

4 days ago

Washington Post announces start of third newsroom

Washington Post executive editor Matt Murray sent out the following on Friday: Dear All, Over the last…

5 days ago